← Leaderboards
Weiqun Yu
Beth Israel Deaconess Medical Center
$4,262,803
Attributed
$4,262,803
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $950.2K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,262,803 · 6
By mechanism
R01$2,592,056 · 2
R00$746,997 · 1
R21$481,250 · 1
U18$262,500 · 1
K99$180,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Dusan Hanidziar$1,775,018
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMediatingSmooth Muscle MyocytesBladderSymptomsPathway InteractionsSignal TransductionFunctional DisorderAgonistExhibitsPlayOveractive BladderLower Urinary Tract SymptomsSmooth MusclePreventSignal PathwayTissuesBladder ControlMuscle ContractionAdenosineBladder DiseasesBladder DysfunctionPurinoceptorKinetics
Grant awards (14)
Cav1.2 in bladder physiology and pathology$486,870
R01 · FY2025 · DK · contact PI
Cav1.2 in bladder physiology and pathology$580,586
R01 · FY2024 · DK · contact PI
Role of Ectonucleotidase in Voiding Function and Dysfunction$369,600
R01 · FY2024 · DK · contact PI
Role of Ectonucleotidase in Voiding Function and Dysfunction$385,000
R01 · FY2023 · DK · contact PI
Role of Ectonucleotidase in Voiding Function and Dysfunction$385,000
R01 · FY2022 · DK · contact PI
Role of Ectonucleotidase in Voiding Function and Dysfunction$385,000
R01 · FY2021 · DK · contact PI
Targeting Cav1.2 to treat Ketamine-Induced Pathology$262,500
U18 · FY2020 · DA · contact PI
Role of Insulin Receptor-mediated Signaling In Underactive Bladder$218,750
R21 · FY2020 · AG · contact PI
Role of Insulin Receptor-mediated Signaling In Underactive Bladder$262,500
R21 · FY2019 · AG · contact PI
Purinergic Regulation of Bladder Interstitial Cells of Cajal$248,999
R00 · FY2017 · DK · contact PI
Purinergic Regulation of Bladder Interstitial Cells of Cajal$248,999
R00 · FY2016 · DK · contact PI
Purinergic Regulation of Bladder Interstitial Cells of Cajal$248,999
R00 · FY2015 · DK · contact PI
Purinergic Regulation of Bladder Interstitial Cells of Cajal$90,000
K99 · FY2014 · DK · contact PI
Purinergic Regulation of Bladder Interstitial Cells of Cajal$90,000
K99 · FY2013 · DK · contact PI